Vertex Pharmaceuticals, Inc. (VRTX)
441.20
+5.55
(+1.27%)
USD |
NASDAQ |
Apr 17, 16:00
442.99
+1.79
(+0.41%)
After-Hours: 20:00
Vertex Pharmaceuticals SG&A Expense (Quarterly) : 487.00M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 4.418B |
| Eli Lilly & Co. | 3.132B |
| Amgen, Inc. | 1.952B |
| Moderna, Inc. | 308.00M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |